Systematic literature review and meta-analysis of clinical outcomes and prognostic factors for melanoma brain metastases.

Tan, Xiang-Lin; Le, Amy; Scherrer, Emilie; Tang, Huilin; Kiehl, Nick; Han, Jiali; Jiang, Ruixuan; Diede, Scott J; Shui, Irene M

Tan, Xiang-Lin; Le, Amy; Scherrer, Emilie; Tang, Huilin; Kiehl, Nick; Han, Jiali; Jiang, Ruixuan; Diede, Scott J; Shui, Irene M.

Afiliação

Tan XL; Merck & Co., Inc., Rahway, NJ, United States.
Le A; Department of Epidemiology, Richard M. Fairbanks School of Public Health, Indiana University, Indianapolis, IN, United States.
Scherrer E; Merck & Co., Inc., Rahway, NJ, United States.
Tang H; Seagen Inc., Bothell, WA, United States.
Kiehl N; Integrative Precision Health, LLC, Carmel, IN, United States.
Han J; Department of Epidemiology, Richard M. Fairbanks School of Public Health, Indiana University, Indianapolis, IN, United States.
Jiang R; Integrative Precision Health, LLC, Carmel, IN, United States.
Diede SJ; Merck & Co., Inc., Rahway, NJ, United States.
Shui IM; Merck & Co., Inc., Rahway, NJ, United States.

Front Oncol ; 12: 1025664, 2022.

Article em En | MEDLINE | ID: mdl-36568199

Palavras-chave

brain metastasis; immunotherapy; melanoma; outcomes; prognostic factors; radiosurgery; targeted therapy

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Tipo de estudo: Observational_studies / Prognostic_studies / Systematic_reviews Idioma: En Ano de publicação: 2022 Tipo de documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google